Tarsus Pharmaceuticals TARS
NASDAQ TARS
$70.98 -0.05 (-0.07%)
As of: Oct 21, 2026 · 9:44 AM EDT

Tarsus Pharmaceuticals (TARS) Raw Materials (2023 - 2024)

Updated

Tarsus Pharmaceuticals' Raw Materials came in at $2.53 million for Q1 2024, unchanged from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Raw Materials (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn
10 Tarsus Pharmaceuticals 3.08 Bn 2.02 Bn 161.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 2.53 Mn
Dec 31, 2023 2.53 Mn
API Access

Tarsus Pharmaceuticals Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=TARS&period=max&api_key=YOUR_API_KEY